Introduction
============

Endothelial dysfunction is critically involved in the pathogenesis of cardio- and cerebro-vascular diseases [@B1]. Although the underlying molecular mechanisms responsible for this pathological cascade remain elusive, it is affirmative that oxidative stress contributes to the etiology [@B2]. Reactive oxygen species (ROS) are therefore considered as crucial detrimental factors in the initiation and progression of neurovascular and cardiovascular disorders [@B3], [@B4]. As a prime member of the ROS family, hydrogen peroxide (H~2~O~2~) has been implicated in severe pathological conditions such as stroke [@B3], [@B4]. Aberrant levels of H~2~O~2~ in endothelial cells can imbalance redox state, destroy endothelial function and result in cellular damage [@B5], [@B6]. As a pro-oxidant molecule, H~2~O~2~ is mainly converted from superoxide spontaneously or following dismutation by superoxide dismutase [@B7]. It is subsequently scavenged by enzymes such as glutathione peroxidase (GPx), catalase, thioredoxins, or peroxiredoxins (Prx) [@B8]-[@B10]. H~2~O~2~ may also be converted to highly reactive hydroxyl radical either by exposure to ultraviolet light or *via* Fenton or Haber-Weiss reactions [@B11], [@B12]. H~2~O~2~ can oxidize macromolecules such as lipids, proteins and DNA to cause cytotoxic damage [@B13]-[@B15]. Nevertheless, on the contrary to its evil "Mr. Hyde" side, recent findings have lighted up its "Dr. Jekyll" role as a second messenger with pro-survival function in several physiological processes [@B16]-[@B18]. As a Janus molecule, H~2~O~2~ has inspired great research interest on its role during redox signaling. It has been presumed that whether H~2~O~2~ is evil or good is determined largely by the context of production, local concentration, trafficking and consumption [@B19], which highlights the importance of detecting H~2~O~2~ dynamically in live organisms.

Numerous strategies have been developed to detect H~2~O~2~, including redox-sensitive fluorescent proteins [@B20]-[@B22], nanotubes [@B23], [@B24], hyperpolarization [@B25], ultrasound [@B26], mass spectrometry [@B27], PET [@B28], chemiluminescence [@B29],[@B30], and H~2~O~2~-responsive small-molecule fluorescent probes [@B31]-[@B34], with the last one attracting particular interest due to its nondestructive nature and high sensitivity. To address the issue of lacking ROS specificity of commercially available probes such as dichlorodihydrofluorescein and dihydrorhodamine [@B35], Chang laboratory have pioneered with aryl boronate-based probes that are capable of undergoing biocompatible reactions with H~2~O~2~ to produce phenols [@B36]-[@B41]. This innovation has benefited research on H~2~O~2~ biology and led to fruitful results [@B42]. Importantly though, however, these aryl boronate-based probes are potentially threatened by their off-target reaction with peroxynitrite (ONOO^-^) which is far more reactive than H~2~O~2~, albeit exists of much lower abundance [@B43]. Furthermore, boric acid by-produced in this process exists as a waste with unknown bioeffect (Figure [1](#F1){ref-type="fig"}). It is therefore envisioned that improvements could be made to devise new probes which release, instead of boric acid, but an agent helpful to ameliorate vascular damage accompanying the fluorescent signal. In our continuous research on the roles of redox-chemistry in the progression of vascular diseases [@B44], we report herein a theranostic probe that can not only sense H~2~O~2~ with high specificity, but is capable of neutralizing the oxidative damage incurred.

Experimental section
====================

Materials
---------

Dry dichloromethane (DCM) was distilled from CaH~2~. Other reagents and chemicals for probe synthesis were obtained from commercial suppliers and used without further purification. Reactions were run under a nitrogen atmosphere and monitored by thin-layer chromatography (TLC) carried out on Silica gel 60 F254 plates supplied by Qingdao Puke Separation Material Corporation, and UV light was used as the visualizing agent. Flash column chromatography was performed using 200-300 mesh silica gel supplied by Qingdao Marine Chemical Factory, Qingdao, China.

Reagents for biological experiments: Dulbecco\'s Modified Eagle\'s Medium (DMEM) was purchased from Invitrogen, and fetal bovine serum (FBS) from Gibco (Carlsbad, CA). Unless otherwise stated, all other reagents and chemicals were obtained from Sigma-Aldrich (St. Louis, MO). Hydrogen Peroxde Assay Kit was from Beyotime Biotechnology.

Instruments
-----------

^1^H NMR spectra were obtained on a Bruker Fourier transform spectrometer (500 MHz) at 25 ^o^C. ^13^C NMR spectra were recorded on a Bruker Fourier transform spectrometer (125 MHz) spectrometer. All NMR spectra were calibrated using the residual solvent (CDCl~3~) as internal reference (^1^H NMR = 7.26, ^13^C NMR = 77.16). All chemical shifts were reported in parts per million (ppm) and coupling constants (J) in Hz. The following abbreviations were used to explain the multiplicities: d = doublet, t = triplet, m = multiplet. IR spectra were taken on a Bruker Vector 22 spectrophotometer as KBr pellets. High resolution mass spectra (HRMS) were measured on an Agilent 6224 TOF LC/MS spectrometer using ESI-TOF (electrospray ionization-time of flight). The reaction process between **AP** and H~2~O~2~ was monitored on a SHIMADZU LCMS-2020 spectrometer. UV-Vis spectra were taken on a HITACHI U-3010 Spectrophotometer. Fluorescence measurements were conducted on an Agilent Cary Eclipse Fluorescence Spectrophotometer with slit widths to be 10 and 10 nm for excitation and emission respectively, and the photomultiplier (PMT) detector voltage was set at medium.

Probe synthesis and characterization
------------------------------------

Procedures for the synthesis of probe **AP1-AP4** were detailed in the [supplementary information](#SM0){ref-type="supplementary-material"}. For the synthesis of probe **AP**, aspirin (0.10 g, 0.56 mmol) was dissolved in dry dichloromethylene (25 mL) and the mixture was cooled to 0 ^o^C with an ice bath. Dry DMF (0.10 mL, 1.3 mmol) and oxalyl chloride (95 μL, 1.1 mmol) were then subsequently added to the mixture dropwise under a nitrogen atmosphere. The reaction was stirred at ambient temperature for 8 h, after which the volatile parts were removed by rotary evaporation. The residue was dissolved in dry dichloromethylene (20 mL), cooled to 0 ^o^C, and then treated subsequently with 2-(2\'-hydroxy-4\'-fluorophenyl) benzothiazole (0.10 g, 0.41 mmol) and Et~3~N (76 μL, 0.56 mmol). The mixture was stirred at ambient temperature for 8 h, after which H~2~O (2.0 mL) was added to quench the reaction. The mixture was diluted with dichloromethylene (30 mL) and then transferred to a separatory funnel. The organic phase was washed with H~2~O (2 × 20 mL) and brine (1 × 20 mL), dried over anhydrous Na~2~SO~4~, and concentrated under reduced pressure to give the crude product which was purified by flash column chromatography (SiO~2~, petroleum ether/EtOAc, 20:1) to yield probe **AP** as a white solid (35 mg, 21% yield).

**R~f~** = 0.55 (20:1, petroleum ether:EtOAc). **^1^H NMR (500 MHz, CDCl~3~, δ):** 8.43 (dd, *J* = 7.9, 1.6 Hz, 1H), 8.15 (dd, *J* = 9.2, 2.9 Hz, 1H), 7.99 (d, *J* = 8.1 Hz, 1H), 7.85 (d, *J* = 8.0 Hz, 1H), 7.73 (td, *J* = 8.0, 1.6 Hz, 1H), 7.48 (tt, *J* = 7.5, 1.0 Hz, 2H), 7.38 (t, *J* = 7.5 Hz, 1H), 7.31 - 7.23 (m, 3H), 2.27 (s, 3H). **^13^C NMR (126 MHz, CDCl~3~, δ):** 169.74 (d, *J* = 10.2 Hz), 162.72, 160.97, 160.54 (d, *J* = 246.6 Hz), 152.84 (d, *J* = 5.7 Hz), 151.76, 144.23 (d, *J* = 3.5 Hz), 135.67, 135.15 (d, *J* = 9.0 Hz), 132.84 (d, *J* = 3.3 Hz), 128.13, 126.60 (d, *J* = 3.3 Hz), 126.42 (d, *J* = 6.5 Hz), 125.75 (d, *J* = 2.6 Hz), 125.56, 124.35 (d, *J* = 1.9 Hz), 123.69, 122.36 (d, *J* = 8.0 Hz), 121.65 (d, *J* = 3.3 Hz), 118.53 (d, *J* = 23.8 Hz), 116.68 (d, *J* = 25.7 Hz), 21.10 (d, *J* = 5.5 Hz). **IR (KBr, cm^-1^):** 3467, 3072, 2361, 1753, 1499, 1423, 1243, 1190, 1040, 754. **ESI-HRMS (*m/z*):** \[M+H\]^+^ calc\'d. for C~22~H~15~FNO~4~S: 408.0706; found 408.0708.

Fluorometric analysis
---------------------

Deionized water was used to prepare all aqueous solutions. All the photophysical characterization experiments were carried out at 37 ^o^C. Phosphate buffer saline (PBS, 100 mM, pH 7.4) was purged with nitrogen for 5 min before use. **AP** was dissolved in DMSO to make a 10 mM stock solution. H~2~O~2~ and other reactive bio-relevant species were prepared as previously described [@B44]. To test the fluorescent responses of **AP** towards H~2~O~2~ or other reactive species, aliquots of probe stock solution were diluted with PBS (with 1‰ cetrimonium bromide) and treated with analytes to make sure both probes and analytes were kept at desired final concentrations. After quick and vigorous shaking, the mixture was allowed standing in the dark at 37 ^o^C for desired time and the fluorescent spectra were then recorded under excitation at 375 nm. The emission spectra were scanned from 400 to 600 nm. All fluorometric experiments were performed in triplicate, and data shown were the average.

Cell culture
------------

EA.hy926 cell line was purchased from ATCC (ATCC CRL-2922). EA.hy926 cells were grown in DMEM medium supplemented with 10% fresh bovine serum in a humidified atmosphere containing 5% CO~2~ at 37 °C. Cultured cells without treatment served as controls.

Confocal fluorescence imaging methods
-------------------------------------

Cells were cultured on glass cover slips overnight and then pre-treated with**AP** for 15 min, followed by being exposed to H~2~O~2~ for indicated time. Cells were then fixed in 4% polyformaldehyde. Nuclei were stained with propidium iodide (PI, sigma) in PBS after fixation. Probe fluorescence in EA.hy926 cells were visualized by confocal microscopy (Nikon A1R) and data were analysed using Image J software (NIH, Bethesda, MD, USA).

CCK-8 assay for cytotoxicity
----------------------------

A Cell Counting Kit-8 (CCK-8) assay (Dojindo; CK04) was used to measure cell viability. EA.hy926 cells were seeded in a 96-well plate at a density of 2.5 × 10^3^ cells per well and incubated overnight. Cells were treated with different concentrations of probe **AP** or negative control for 24 h, then the medium was changed to fresh one (100 μl) and CCK-8 reagent (10 μl) was added. Following 1 h of incubation, cell viability was determined by measuring the optical absorbance at 450 nm with a multimode reader (Beckman Coulter; DTX880).

Oxygen and glucose deprivation (OGD) exposure
---------------------------------------------

The oxygen and glucose deprivation (OGD) model was used to mimic the ischemia-like condition in live cells [@B45]. Briefly, cell culture medium was replaced with glucose-free HBSS (Hank\'s balanced salt solution), and cells were then placed in an airtight experimental hypoxia chamber (Billups-Rothenberg) containing a gas mixture of 95% N~2~ and 5% CO~2~. Cells were exposed to OGD for 0.5, 1 and 2 h to induce injury. Cells without OGD treatment were served as controls.

Middle cerebral artery occlusion (MCAO) model
---------------------------------------------

The transient ischemia/reperfusion MCAO model was used to stimulate overproduction of H~2~O~2~ in mice. Model preparation was carried out as previously described [@B45]. Animal procedures were approved by the Committee on Animal Experiments at the Zhejiang University. The mice were subjected to one hour of ischemia followed by reperfusion. The brain was then isolated and slices were prepared 24 h after ischemia. The slices were then treated with probe **AP** for 15 min, and visualized by confocal microscopy (Nikon A1R). Data were analysed using Image J software (NIH, Bethesda, MD, USA).

Zebrafish care and maintenance
------------------------------

A wild-type AB strain of zebrafish (Batch Number 20150319) was used in the present study. The zebrafish were housed in a light and temperature controlled aquaculture facility with a standard 14-10 h light-dark conditions and fed with live brine shrimp twice daily and dry flake once a day. Four to five pairs of zebrafish were set up for natural mating every time, 200-300 embryos can thereby be generated. Embryos were maintained at 28 ^o^C in fish water (0.2% Instant Ocean Salt in deionized water, pH 6.9-7.2, conductivity 480-510 µs/cm, and hardness 53.7-71.6 mg/L CaCO~3~). Embryos were washed and staged at 6 and 24 hpf (hours post fertilization).

Zebrafish thrombosis model
--------------------------

3-Dpf zebrafish were chosen to prepare thrombosis model using a platelet agonist (arachidonic acid, 80 μM) challenge method. Zebrafish treated with 0.1% DMSO was served as a vehicle control. Zebrafish from each group were randomly selected for visually qualitative assessment of the thrombus formation in the caudal vein at the lateral view with a dissecting stereomicroscope. The resting zebrafish were stained with *O*-dianisidine to quantify the heart red blood cells (RBCs) (hemoglobin level) which reversely correlated with the degree of thrombosis. The optimal concentration and incubation time of arachidonic acid treatment were selected according to the qualitative and quantitative results of thrombosis. Heart RBCs counts were performed using the NIS-Elements D3.10 image analysis software (Nikon). The effect of a test drug was calculated based on the formula below:

Efficacy (%)= \[\[S(drug)-S(model)\]/\[S(vehicle)-S(model)\]\]x100%

A positive percentage means that a tested drug could prevent and/or treat thrombus and a negative percentage suggests that the tested drug had no effect on thrombosis in the zebrafish model.

Results and Discussion
======================

Initially, to fulfill the task of therapy, aspirin was judiciously selected as the prime building block attributing to its vascular-beneficial effects such as antioxidant, anti-inflammatory and antiplatelet [@B46]. In particular, aspirin is not only efficient in reducing stroke incidence, but can also attenuate clinical deficits at stroke onset [@B47]. To orchestrate the therapeutic effect of aspirin with a fluorescent diagnostic signal for H~2~O~2~, it should be combined with a fluorophore *via* a H~2~O~2~-sensitive linkage. Since H~2~O~2~ with p*K*a of 11.75 is slightly more acidic than H~2~O (p*K*a 13.99), we surmised that H~2~O~2~ in neutral aqueous solution might catalyze the hydrolysis of certain esters. Therefore, aspirin was combined with 2-(2\'-hydroxy-4\'-fluorophenyl) benzothiazole fluorophore with an ester bond to construct probe **AP** (Figure [1](#F1){ref-type="fig"}). We reasoned that the ester bond would block the excited state intramolecular proton transfer process (ESIPT) in the fluorophore which is essential for illumination [@B48], whereas the nitrogen atom on the fluorophore skeleton could bring HOO^-^ within close proximity to the ester *via* a hydrogen bonding to accelerate the hydrolysis. **AP** was facilely prepared as detailed in the experimental section.

The optical response of **AP** towards H~2~O~2~ was tested in PBS (100 mM, pH 7.4). As shown in Figure [2](#F2){ref-type="fig"}A, **AP** showed the absorption maximized at 297 nm (*c* 30 μM, 15 463 M^-1^ cm^-1^). Treatment of H~2~O~2~ (1.0 mM) induced a time-dependent decrease of the original peak and the emergence of a new red-shifted band peaked at 336 nm, indicating the slow hydrolysis of the ester to yield the -OH group as a better auxochrome. Coinciding with the UV-Vis absorption response, H~2~O~2~ treatment also induced a time-dependent increase of **AP** fluorescence centred at 476 nm (Figure [2](#F2){ref-type="fig"}B, Figure [S1](#SM0){ref-type="supplementary-material"}-S4). When the response was observed over longer time, completion could be detected in 2 hours (Figure [S5](#SM0){ref-type="supplementary-material"}). Furthermore, **AP** (10 μM) responded to H~2~O~2~ with fluorescence enhancement in a dose-dependent manner (Figure [2](#F2){ref-type="fig"}C) with H~2~O~2~ concentrations higher than 1 mM bringing the response to its maximum (F~max~). Interestingly, the Napierian logarithm of F~max~ minus F correlated linearly with H~2~O~2~ concentrations in the range of 0-500 μM (Figure [S6](#SM0){ref-type="supplementary-material"}, S7). Notably, the detection limit of the probe was found to be as low as 2.5 μM (Figure [S8](#SM0){ref-type="supplementary-material"}). These results suggest the great potential of probe **AP** to quantify H~2~O~2~ in PBS medium. The selectivity of **AP** towards various reactive species was also evaluated. Among the various biologically-relevant reactive species, only H~2~O~2~ was found capable of triggering on the fluorogenic response of **AP** with a 11-fold intensity increase, which is at least 8-fold more selective than ONOO^-^, a common interferent for boronate-based probes (Figure [2](#F2){ref-type="fig"}D and Figure [S9](#SM0){ref-type="supplementary-material"}). Furthermore, the effect of pH on the stability of probe **AP** was also studied. **AP** is quite stable below pH 7.0. Though slight hydrolysis of the ester group was observed at pH 7.5 as indicated by the 2.6 folds of fluorescence intensity increase, this increase is much smaller than that caused by H~2~O~2~ (Figure [S10](#SM0){ref-type="supplementary-material"}). Given the fact that cytosol generally has a pH of 7.2 and most organelles are below pH 7.2 [@B49], probe **AP** should be stable enough to stand cellular pH gradients.

With the fluorogenic response of probe **AP** towards H~2~O~2~ systematically characterized, we next evaluated if aspirin would be released in this process as surmised in Figure [1](#F1){ref-type="fig"}. The reaction between **AP** and H~2~O~2~ in PBS was therefore tracked by LC-MS analysis to determine the structures of the products. Prior to this study, the LC-MS spectra of a mixture of **AP**, 2-(2\'-hydroxy-4\'-fluophenyl) benzothiazole fluorophore, aspirin and salicylic acid were recorded for reference. It turned out that treatment of **AP** with H~2~O~2~ induced a gradual decrease of the probe, accompanied by the simultaneous increase in the formation of the free fluorophore and aspirin in the form of salicylic acid (Figure [S11](#SM0){ref-type="supplementary-material"}-S15), indicating the efficient release of aspirin and the fluorophore triggered by H~2~O~2~. To make further confirmation, probe **AP** was treated with H~2~O~2~ in a flask, and 2-(2\'-hydroxy-4\'-fluophenyl) benzothiazole fluorophore was isolated and characterized by ^1^H NMR, further consolidating the mechanism shown in Figure [1](#F1){ref-type="fig"} (Figure [S16](#SM0){ref-type="supplementary-material"}).

To find out if other fluorophores could also work in this design, probe **AP1**-**AP4** were prepared by esterifying the phenol hydroxyl group in an acylnaphthalene, coumarin, naphthalimide, or hemicyanine (Figure [S17](#SM0){ref-type="supplementary-material"}). When their responses towards H~2~O~2~ were tested in comparison with probe **AP**, all the probes were found active with probe **AP** being the most sensitive one (Figure [S18](#SM0){ref-type="supplementary-material"}). This result demonstrates the generality of the acetosalicylic phenolic ester as a H~2~O~2~-responsive trigger.

Having confirmed H~2~O~2~-triggered release of the free fluorophore and aspirin from probe **AP** in aqueous solution, we moved on to investigate the feasibility of **AP** to image H~2~O~2~ in EA.hy926 endothelial cells by confocal fluorescence microscopy. For this purpose, the cytotoxicity of probe**AP** was first evaluated by CCK8 assay. After treating EA.hy926 cells with various concentrations of **AP**, cell viability was monitored with a CCK8 kit and no significant **AP** toxicity was observed (Figure [S19](#SM0){ref-type="supplementary-material"}). Then, the response of EA.hy926 cells to probe **AP** was recorded. As shown in Figure [3](#F3){ref-type="fig"}, almost no detectable fluorescence signal was observed in control cells loaded with only probe **AP**. However, significant elevation of **AP** fluorescence was observed when the cells were exposed to exogenous H~2~O~2~, and the intracellular fluorescence increased in a H~2~O~2~ dose-dependent way. Time-dependent increase of **AP** fluorescence was also observed after the cells were exposed to H~2~O~2~ (50 μM) (Figure [S20](#SM0){ref-type="supplementary-material"}). Noteworthy, similar results were obtained in HUVEC cells, for which exogenous H~2~O~2~ exposure resulted in both H~2~O~2~ dose-dependent and time-dependent intensification of intracellular fluorescence (Figure [S21](#SM0){ref-type="supplementary-material"}, S22), indicating the potential of **AP** to track H~2~O~2~ levels in live cells.

The sensitivity of probe **AP** to image endogenous H~2~O~2~ in live cells was also tested. Since aberrant accumulation of H~2~O~2~ has been reported in the progression of ischemic endothelial injury [@B50], we therefore evaluated if probe **AP** could track the dynamic change of endogenous H~2~O~2~ formation during endothelia injury. For this purpose, oxygen-glucose deprivation (OGD) stimulation model was employed to induce ischemic endothelial injury, and the fluorescent response of live cells after OGD stimulation was recorded. We first confirmed that probe **AP** was inert to OGD reagents (Figure [S23](#SM0){ref-type="supplementary-material"}). When EA.hy926 cells subjected to OGD treatment over 0.5-2 h were stained with **AP**, time-dependent accumulation of intracellular **AP** fluorescence was observed, which agreed well with the staining results obtained with a commercial Hydrogen Peroxde Assay Kit (Beyotime Biotechnology) (Figure [S24](#SM0){ref-type="supplementary-material"}), indicating the sensitivity of **AP** for endogenous H~2~O~2~ in live cells. This result also reveals the quick destroy of native redox homeostasis and the emergence of a more oxidative environment within endothelial cells upon injury, which is in agreement with previous reports [@B50].

Having confirmed the ability of probe **AP** to image H~2~O~2~ accumulation during endothelial cell injury, we moved on to investigate if H~2~O~2~-triggered release of aspirin would display therapeutic effect against H~2~O~2~-induced endothelial apoptosis. Cell apoptosis was determined using flow cytometry with annexin V-FITC/propidium iodide (PI). We first confirmed that probe **AP** (25 μM) by itself had no adverse effect on cell viability as **AP** treatment gave similar staining results as the control group. Furthermore, H~2~O~2~ (200 μM, 2 h) treatment was found to significantly induce elevation in the fraction of annexin V/PI positive cells (14.90%) compared to the control group (1.90%), suggesting its cytotoxicity. By contrast, **AP** incubation significantly reduced H~2~O~2~-induced cell apoptosis (2.90%; Figure [5](#F5){ref-type="fig"}A and Figure [S25](#SM0){ref-type="supplementary-material"}). Interestingly, this was particularly evident in HUVEC by flow cytometry assay (Figure [S26](#SM0){ref-type="supplementary-material"}). Furthermore, the protective effect of probe **AP** against H~2~O~2~-induced endothelial cell apoptosis was confirmed by reduced phosphorylation of JNK, ERK and p38 in H~2~O~2~-**AP**-treated cells in compare to H~2~O~2~-treated ones (Figure [5](#F5){ref-type="fig"}B-[5](#F5){ref-type="fig"}E). Taken together, these data support the bifunctional roles of **AP** either for live cell imaging or to ameliorate endothelial injury during H~2~O~2~-induced oxidative stress.

Having confirmed the good performance of probe **AP** in live cells, we next expand the scope to live tissues, and a middle cerebral artery occlusion (MCAO) model was used to induce oxidative damage to the brain neurovascular system. Mice brain was isolated 24 h after ischemia and slices were prepared. When the slices were stained with probe **AP**, strong **AP** fluorescence was observed in the brain ischemic region of MCAO mice (Figure [6](#F6){ref-type="fig"}). However, no significant **AP** fluorescence was observed in the sham group. These results demonstrate the sensitivity and specificity of probe **AP** to image neurovascular cell injury.

To further confirm the endothelial-protective effect of probe **AP** in zebrafish model, its anti-thrombotic effect was evaluated with aspirin as a positive control, because endothelial cell injury has been considered as the underlying pathogenesis of microvascular thrombosis and ischemia. Zebrafish thrombosis model was prepared as described and hemoglobin staining was used to indicate the degree of intravascular thrombosis [@B51]. As shown in Figure [7](#F7){ref-type="fig"}, in contrast to the normal heart RBCs/hemoglobin staining in the control group, arachidonic acid (a platelet agonist) treatment resulted in only weak staining. However, probe**AP** (8.3 μM or 25 μM) treatment was observed to be able to significantly inhibit arachidonic acid-induced thrombosis formation in zebrafish compared to the vehicle group, and the potency was **AP** dose-dependent (Figure [7](#F7){ref-type="fig"}A-B). Furthermore, similar results were obtained in the caudal vein of Zebrafish with thrombosis (Figure [7](#F7){ref-type="fig"}C), for which the preventive efficacy on thrombosis formation was quantified to be 78% for aspirin (139 μM), 41% for probe **AP** (8.3 μM) and 52% for probe **AP** (25 μM), respectively (Figure [7](#F7){ref-type="fig"}D).

Conclusions
===========

In summary, targeting the oxidative microenvironment of vascular diseases represented by the overproduction of H~2~O~2~, we have developed the first theranostic probe for its simultaneous imaging and neutralization by combining a fluorophore with an endothelial-protective agent *via* a H~2~O~2~-sensitive bond. The probe has been proven suitable for imaging native H~2~O~2~ generation in live cells, and is capable of eliciting protective effects against both H~2~O~2~-induced endothelial cell apoptosis and vascular pathology in Zebrafish thrombosis mode. The probe should hold promise to serve as a dual functional imaging tool to explore H~2~O~2~ signalling under a variety of pathological contexts. The design strategy illustrated in this work should be inspiring for future probe design.

This work was supported in part by National Key Research and Development Program of China (2016YFE0125400), National Natural Science Foundations of China (81473202, 81573411, 21642007), Zhejiang Provincial Natural Science Foundation of China (Z16H310003, LY15H300003), Zhejiang Provincial Science and Technology Planning Project (2017C33053), Zhejiang Province Program for Cultivation of High-level Health talents.

Supplementary Material {#SM0}
======================

###### 

Figure S1-S26, synthesis and characterization of **AP1**-**AP4**, NMR traces of probe **AP**.

###### 

Click here for additional data file.

![Comparison of previous arylboranate-H~2~O~2~ chemistry-based probe, and probe **AP** in this work. For the same fluorophore, boric acid-based probe showed poor selectivity for H~2~O~2,~ while aspirin-based probe **AP** was almost immune to ONOO^-^. Data were the normalized fluorescent intensity of the probes (10 μM) at 460 nm before or after the treatment of H~2~O~2~ (500 μM) or ONOO^-^ (20 μM) for 30 min.](thnov07p3803g001){#F1}

![Photophysical responses of **AP** to H~2~O~2~. A) UV-Vis absorption response of **AP** (30 μM) towards H~2~O~2~ (1.0 mM) as time lapsed. B) Fluorescence response of **AP** (10 μM) towards H~2~O~2~ (200 μM) as time lapsed. C) Fluorescence response of **AP** (10 μM) towards various concentrations of H~2~O~2~ at a time point of 30 min. D) Fluorescent responses of **AP** (10 μM) toward various analytes (200 μM) after a reaction time of 30 min, where F represents the fluorescent intensity of **AP** at 476 nm after the treatment of various analytes, and F~0~ represents the intensity of blank **AP** solution at 476 nm. (1) probe blank, (2) H~2~O~2~, (3) ^1^O~2~, (4) O~2~^-^, (5) ClO^-^, (6) THBP, (7) ONOO^-^, (8) NO, (9) NO~2~^-^, (10) NO~3~^-^, (11) GSH, (12) Cys, (13) Hcy, (14) Gly, (15) Ala, (16) Mg^2+^, (17) Ca^2+^, (18) Fe^3+^, (19) Fe^2+^, (20) K^+^, (21) Cu^2+^, (22) Zn^2+^. All fluorescence data were collected in PBS (pH 7.4, 100 mM) at 37^o^C with λ~ex~ 375 nm. UV data were obtained in PBS with 50% EtOH as co-solvent.](thnov07p3803g002){#F2}

![Representative confocal images showed dose-dependent increase of **AP** fluorescence in endothelial cells. Cells were seeded on 24-well glass cover slips overnight and then pre-incubated with **AP** (5.0 μM) for 15 min, followed by challenging without or with H~2~O~2~ (25-200 μM) for 15 min. **AP** fluorescence (green, 460 nm) was excited at 405 nm. PI counterstaining indicated nuclear localization (blue, 620 nm). All images were captured using a Nikon A1R confocal microscope with the same settings. Overlay image of all captured fluorescence intensities are shown. Scale bar represents 20 μm.](thnov07p3803g003){#F3}

![Visualizing endogenous H~2~O~2~ formation using **AP** in endothelial cells following oxygen-glucose deprivation (OGD). The representative confocal images showed temporal changes of **AP** fluorescence (green, 460 nm) in EA.hy926 endothelial cells over 0.5 to 2 h following OGD. PI counterstaining indicated nuclear localization (blue, 620 nm). Overlay image of **AP** fluorescence and PI are shown. Scale bar represents 20 μm.](thnov07p3803g004){#F4}

![The protective role of **AP** against H~2~O~2~-induced endothelial apoptosis. A) The apoptosis of endothelial cells was labelled with annexin V-FITC/propidium iodide (PI) and determined using flow cytometry. EA.hy926 cells were seeded on 12-well plates overnight and then pre-incubated with **AP** (25 μM) for 15 min, followed by stimulation with H~2~O~2~ (200 μM, 2 h or 4 h) in HBSS medium. B) The representative blots for phosphorylation of JNK, ERK and p38 in the presence of **AP** probe upon H~2~O~2~ (200 μM, 12 h) exposure in DMEM medium. Summary of phospho-JNK (C), phospho-ERK (D) and phospho-p38 (E) were indicated as densitometric values. \*\**p* \< 0.01.](thnov07p3803g005){#F5}

![Visualizing endogenous H~2~O~2~ formation using **AP** in MCAO mouse. The representative confocal images showed changes of **AP** fluorescence (green) in brain ischemic region in MCAO mice. Insert frame: Brain ischemic region. Scale bar represents 2 mm.](thnov07p3803g006){#F6}

![The antithrombotic effect of probe**AP**. Zebrafish treated with arachidonic acid for 1.5 h were used as thrombosis model. A) Effects of probe**AP** on heart RBCs in thrombotic zebrafish. The heart red blood cells were stained with *o*-dianisidine staining. The heart RBCs intensity of zebrafish increased following **AP** probe treatment (1.5 h) in the presence of arachidonic acid (80 µM). B) Quantification data for Figure A. C) Effect of **AP** probe on thrombus formation in the caudal vein under a dissecting stereomicroscope. Images from aspirin or **AP** probe treatment are shown from a representative caudal vein of zebrafish from each group. Thrombus formation was markedly reduced in zebrafish treated with **AP** probe (1.5 h) in the presence of arachidonic acid. D) The therapeutic efficacy of **AP** probe on thrombosis formation.](thnov07p3803g007){#F7}
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